Pyxis Oncology Inc - Current Cash Runway Expected to Fund Development Into 2H 2026Dec 19 (Reuters) - Pyxis Oncology Inc Pyxs.o:
2023年12月19日（路透社） - Pyxis Oncology Inc Pyxs.o:
Pyxis Oncology Announces Portfolio Prioritization, Focusing Resources on Its Lead Clinical Program, Pyx-201
Pyxis Oncology Inc - - Company
Pyxis Oncology Inc - Current Cash Runway Expected to Fund Development Into 2H 2026
Pyxis Oncology Inc - Will Focus Resources on Advancing Its Lead Asset, Pyx-201
Pyxis Oncology Inc - Second Clinical Program, Pyx-106 Is Being Deprioritized
Pyxis腫瘤學宣佈投資組合優先級，集中資源於其主導臨牀項目Pyx-201
Pyxis腫瘤學公司 - - 公司
Pyxis Oncology Inc - 預計當前現金儲備將支持開發到2026年下半年
Pyxis Oncology Inc - 將集中資源推進其主要資產，Pyx-201
Pyxis Oncology Inc - 第二臨牀項目，Pyx-106 正在被降低優先級
Source Text: Id:Ngnx9Fjpzf
來源文本： Id:Ngnx9Fjpzf
Further Company Coverage: Pyxs.o
進一步公司報道: Pyxs.o
((Reuters.briefs@Thomsonreuters.com;))
（（路透社.簡訊@湯森路透.com;））
